Olgram

Olgram, founded in 2019, is a biotechnology firm headquartered in France. The company is pioneering the development of marine-inspired molecules with a mission encapsulated by its slogan: "Marine-inspired molecules to fight immunological diseases."

Tackling the lack of therapies for immune collapse following severe trauma, Olgram is targeting a critical medical gap. Traumatic brain injury, a leading cause of death for those under 30, has no existing treatments to address subsequent immune collapse. Olgram, grounded in cutting-edge immunology and biotechnology, is leading efforts to innovate within the field of post-traumatic immune restoration.

The company is fortified by four patents, underlining its commitment to proprietary research and innovation. In June 2024, Olgram received a significant boost with a €2.60M grant investment from Bpifrance. This funding marks a vote of confidence in Olgram's potential to transform trauma recovery treatments and offers promising returns for future investors.